I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5 Febuxostat Intermediate Purity >99.0% Factory
I-Ruifu Chemical Supply Febuxostat Related Intermediate:
I-Febuxostat CAS 144060-53-7
I-Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
I-Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
I-Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
I-Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
I-Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Igama Lekhemikhali | I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate |
Omqondofana | Febuxostat Intermediate |
Inombolo ye-CAS | 161797-99-5 |
Inombolo yeCAT | I-RF-PI1122 |
Isimo Sesitoko | Esitokweni, Amandla Okukhiqiza Amathani ayi-100/Ngonyaka |
I-Molecular Formula | I-C13H13NO3S |
Isisindo samangqamuzana | 263.31 |
I-Melting Point | 180 ℃ |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ephuzi Okukhanyayo ukuya kokumhlophe |
Ukuhlonza | Nge-HPLC;Ibhalwe ngu-HNMR |
Ukulahlekelwa Ekumisweni | <0.50% |
Izinsalela ku-Ighition | <0.30% |
Ukungcola Okukodwa | <0.50% |
Ukungcola Okuphelele | <1.00% |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.0% (nge-HPLC) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Febuxostat (CAS: 144060-53-7) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) isetshenziswa ekuhlanganiseni kwe-Febuxostat (CAS: 144060-53-7), i-xanthine oxidase/xanthine dehydrogenase inhibitor.Isetshenziselwa ukwelapha i-hyperuricemia kanye ne-gout engapheli.I-40-120 mg/ngosuku i-febuxostat yafakazelwa ukuthi iyasebenza ekwehliseni amazinga e-serum urate lapho isetshenziswa ukuphatha i-hyperuricemia ezigulini ezine-gout.I-Fabuxostat itholwe yi-Teijin Pharmaceuticals futhi yanikezwa ilayisense ye-TAP Pharmaceuticals (okwamanje eyingxenye ye-Takeda Pharmaceuticals) futhi yagunyazwa e-US ukuze zelashwe i-hyperuricemia ezigulini ezine-gout.